Important Information for ModivCare Inc. Securities Holders: Rosen Law Firm Reminds of Upcoming Deadline
NEW YORK, March 29, 2025 – Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ModivCare Inc. (NASDAQ: MODV) between November 3, 2022, and September 15, 2024 (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline. The lawsuit seeks to recover damages for ModivCare investors under the Securities Exchange Act of 1934.
Background on the Lawsuit
The complaint alleges that during the Class Period, ModivCare and certain of its executives made false and misleading statements and failed to disclose material information about the company’s business, operations, and financial condition. Specifically, the complaint alleges that ModivCare failed to disclose: (1) that the company was experiencing significant operational challenges in its home health business, including issues with patient acquisition and retention, and that these issues were negatively impacting the company’s financial results; (2) that ModivCare’s financial statements for the periods ended March 31, 2022, and June 30, 2022, contained material errors; and (3) that as a result of the foregoing, the company’s financial statements were not reliable and could not be relied upon to make informed investment decisions.
Impact on Individual Investors
If you purchased ModivCare securities during the Class Period and suffered a loss, you may be eligible to participate in the class action lawsuit. The lead plaintiff deadline is March 31, 2025. To learn more, please contact the Rosen Law Firm at 866-767-3653 or via email at [email protected] or [email protected]. You may also visit the firm’s website at
Impact on the World
The lawsuit against ModivCare highlights the importance of transparency and accuracy in financial reporting. The alleged failure of ModivCare to disclose material information about its business and financial condition could potentially harm investors who relied on the company’s statements when making investment decisions. Furthermore, it could also undermine investor confidence in the broader healthcare sector, potentially leading to increased scrutiny and regulatory action.
Conclusion
The Rosen Law Firm reminds investors of the upcoming March 31, 2025 lead plaintiff deadline in the ModivCare class action lawsuit. The lawsuit alleges that ModivCare and certain of its executives made false and misleading statements and failed to disclose material information about the company’s business, operations, and financial condition during the Class Period. If you purchased ModivCare securities during the Class Period and suffered a loss, you may be eligible to participate in the class action lawsuit. For more information, please contact the Rosen Law Firm at 866-767-3653 or via email at [email protected] or [email protected]. The lawsuit underscores the importance of transparency and accuracy in financial reporting, and could potentially have far-reaching implications for the healthcare sector and investor confidence.
- Rosen Law Firm reminds ModivCare securities holders of the upcoming March 31, 2025 lead plaintiff deadline
- The lawsuit alleges that ModivCare and certain executives made false and misleading statements
- If you purchased ModivCare securities during the Class Period and suffered a loss, you may be eligible to participate in the class action lawsuit
- The lawsuit highlights the importance of transparency and accuracy in financial reporting
